Bottom line
BCGS vs MDISX: the short answer
BCGS (Bancreek Global Select ETF) and MDISX (Franklin Mutual Global Discovery Fund) are both etfs.
BCGS is cheaper at 0.8% vs 0.95% — a difference of $15 a year per $10,000 invested.
Updated Nov 19, 2026
BCGS vs MDISX side by side
| BCGS | MDISX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Innovator | Franklin Templeton |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.8% | 0.95% |
| Annual cost per $10k | $80 | $95 |
| 10-yr cost on $10k (prospectus) | — | $1,167 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +23.7% |
| 5-yr return (annualized) | — | +12.3% |
| 10-yr return (annualized) | — | +8.9% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $40.2M | $9.0B |
| Number of holdings | 55 | 72 |
| Portfolio turnover | — | 42% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BCGS and MDISX share none of their top holdings.
BCGS top 10
- Sk Hynix Inc — 2.53%
- Applovin Corp — 2.26%
- Spotify Technology Sa — 2.14%
- Eli Lilly & Company — 2.09%
- Indra Sistemas Sa — 2.03%
- Sk Square Co Ltd — 2.01%
- Amphenol Corp — 2.00%
- Broadcom Inc — 1.99%
- Ucb Sa — 1.98%
- Benefit Systems Sa — 1.96%
MDISX top 10
- Microsoft Corp. — 2.97%
- Merck & Co., Inc. — 2.65%
- BNP Paribas SA — 2.64%
- Roche Holding AG — 2.34%
- EOG Resources, Inc. — 2.24%
- British American Tobacco plc — 2.20%
- Bank of America Corp. — 2.20%
- Arthur J Gallagher & Co. — 2.10%
- Airbus SE — 2.09%
- AerCap Holdings NV — 2.09%
FAQ
What is the difference between BCGS and MDISX?
BCGS (Bancreek Global Select ETF) and MDISX (Franklin Mutual Global Discovery Fund) are both etfs. BCGS is cheaper at 0.8% vs 0.95% — a difference of $15 a year per $10,000 invested.
Which is cheaper, BCGS or MDISX?
BCGS has the lower expense ratio (0.8%).
Should I own both BCGS and MDISX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.